// App-Quantinova.ai

BSH2020‐OR‐043 : When is immune thrombocytopenia not immune thrombocytopenia? Using high‐throughput sequencing to distinguish patients with inherited thrombocytopenia and diseases of immune dysregulation

Researchers

Presenter

  • N. Joshi

Principal Investigators

  • M. Gallanagh

  • H. Lango-Allen

  • K. Downes

  • I. Simeoni

  • N. Cooper

Medical Centers

  • Department of Neurosurgery, Imperial College Healthcare NHS Trust, London, UK

  • NIHR BioResource, Cambridge University Hospitals, Cambridge, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Nucleotide-binding oligomerization domain-containing protein 2

  • Phospholipase C-gamma-2

  • ETV6-RUNX1

  • Transcription factor Maf

  • Tubulin beta-1 chain

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved